Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by the aberrant accumulation of extracellular matrix in the lungs. nintedanib is one of the two FDA-approved drugs for IPF treatment; however, the exact pathophysiological mechanisms of fibrosis progression and response to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Principi, Lucrezia, Ferrini, Erica, Ciccimarra, Roberta, Pagani, Lisa, Chinello, Clizia, Previtali, Paolo, Smith, Andrew, Villetti, Gino, Zoboli, Matteo, Ravanetti, Francesca, Stellari, Franco Fabio, Magni, Fulvio, Piga, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002924/
https://www.ncbi.nlm.nih.gov/pubmed/36901840
http://dx.doi.org/10.3390/ijms24054410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002924/
https://www.ncbi.nlm.nih.gov/pubmed/36901840
http://dx.doi.org/10.3390/ijms24054410

Ejemplares similares